Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference Transcript
All right. Thank you, everybody, for being here. I'm Lee Hambright, U.S. medical device analyst at Bernstein. I hope everybody is having a good conference so far. We are really pleased to be hosting Johnson & Johnson. We have CEO, Alex Gorsky.
Before we get going, Matt Stuckley will give a few comments. Then we'll jump into a fireside chat format.
Great. Thanks, Lee. Good afternoon, everyone. Please be aware that some statements made today may be considered forward-looking or utilize non-GAAP measures. Please refer to our SEC filings, in particular our 10-K, which discuss the risk and uncertainties around forward-looking statements as well as our website at investor.jnj.com for reconciliations to comparable GAAP measures. Finally, any performance measures made today represent results through and including the first quarter of 2019. Thank you very much.
Lee?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |